Sign up to receive 5 free days of our daily summary for tech news.

Special Offer: Try out The Information today for only $10/month for your first 3 months. 

In Washington, a New Wrangle Over Digital Health Rules

Recent moves by the U.S Congress to curtail the Food and Drug Administration’s oversight of medical apps and other digital health products and loosen regulation of the sector is meeting surprising resistance from some entrepreneurs and health startups, who argue that a sound and consistent regulatory regime will be good for the industry.

The FDA has come under fire from some quarters as an impediment to innovation in the sector. The agency curtailed the genetic testing service of the high-profile startup 23 and Me, for example, and Congressional advocates of deregulation say that certain “low risk” technologies like clinical software shouldn’t be subject to an FDA approval process that can be expensive and time-consuming.

A letter sent last month to the FDA by six Senators pushes the agency to clarify how it will regulate the medical app space without hampering innovation. Meanwhile legislation has been introduced in both chambers of Congress to restrict the FDA’s authority over medical software, with one bill proposing that the National Institute of Standards and Technology set some of the rules.

But medical entrepreneurs say that regulatory certainty is the most important thing, and that wrangling between Congress and the FDA will only confuse matters and delay the establishment of clear rules. A much-anticipated FDA report on regulatory strategies for healthcare IT was supposed to be released by the end of March, but has not yet appeared.

What Is The Information?

Notes bb3aa5069205d702dda37fc71dc6f1c59df2310c4379304e9f1199f052af4884

Exclusive Articles

We broke it first. Receive original reporting you won't read anywhere else from the largest newsroom in tech.

Notebook b5103017ee163370a1667c9ce59ab0ef023875a17888105d26c185cadf31bb69

Daily news analysis

Every weeknight, we'll send you our reporters’ views on the day’s top tech news—distilled into one email.

Conference calls c9e664e8b96ee347d3e92b8309938f268422b9db98cfabca5c826fbb75054b23

Conference calls

Get access to our reporters and other top executives with monthly deep-dive calls into topics like startups and autonomous vehicles.

Events 499acedd16cffc41445edd76bfd302b2836c2a27419890f17130a6b10e2aa3df

Special Events

For no extra fee, get access to more than a dozen events yearly, from intimate dinners to larger gatherings with marquee speakers.

What else is included in my subscription?

Become a contributor

Share your views and find other subscribers by completing your profile. You’ll be listed in our contributor directory.

Slack community

Discuss topics and current events with our subscriber-only Slack group and share news about your company with other subscribers.

Annual Subscriber only benefits:

Org Charts

Access the only collection of tech company org charts. Our expanding database includes companies like Amazon, Snap, and Uber.

Crypto Newsletter

Our experts investigate the latest in the crypto world to keep you in-the-know about the movements of digital currencies.

Stay up to date on Silicon Valley

Sign up for Jessica Lessin’s (The Information’s CEO & Founder) free Saturday newsletter and also receive a complimentary week of our daily afternoon tech commentary email.

Already a subscriber? Log in here

Recent Articles

Startups Media/Telecom

VCs in Fitbit Paid a Price for Not Selling Early

By Alfred Lee and Reed Albergotti


Intel Plans to Shut Down Smart Glasses Group

By Aaron Tilley

Venture Capital Markets

These Tech Firms Destroyed Value the Fastest

By Alfred Lee


How Fitbit Survived in Apple’s Shadow

By Aaron Tilley

“Companies have invested up to a million dollars into developing an app that they believe is worth more than a 99 cent download. FDA approval and an assurance of higher quality is a mark that elevates their products. The implied higher quality is a defining difference between them and the competition.”